"Tumor Cells, Cultured" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.
| Descriptor ID |
D014407
|
| MeSH Number(s) |
A11.251.860
|
| Concept/Terms |
Tumor Cells, Cultured- Tumor Cells, Cultured
- Neoplastic Cells, Cultured
- Cultured Neoplastic Cells
- Cell, Cultured Neoplastic
- Cells, Cultured Neoplastic
- Cultured Neoplastic Cell
- Neoplastic Cell, Cultured
- Cultured Tumor Cells
- Cell, Cultured Tumor
- Cells, Cultured Tumor
- Cultured Tumor Cell
- Tumor Cell, Cultured
|
Below are MeSH descriptors whose meaning is more general than "Tumor Cells, Cultured".
Below are MeSH descriptors whose meaning is more specific than "Tumor Cells, Cultured".
This graph shows the total number of publications written about "Tumor Cells, Cultured" by people in this website by year, and whether "Tumor Cells, Cultured" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 135 | 137 |
| 1995 | 1 | 149 | 150 |
| 1996 | 2 | 162 | 164 |
| 1997 | 1 | 180 | 181 |
| 1998 | 6 | 216 | 222 |
| 1999 | 2 | 225 | 227 |
| 2000 | 9 | 254 | 263 |
| 2001 | 6 | 278 | 284 |
| 2002 | 8 | 321 | 329 |
| 2003 | 4 | 249 | 253 |
| 2004 | 1 | 99 | 100 |
| 2005 | 1 | 94 | 95 |
| 2006 | 0 | 88 | 88 |
| 2007 | 1 | 62 | 63 |
| 2008 | 0 | 51 | 51 |
| 2009 | 0 | 55 | 55 |
| 2010 | 0 | 60 | 60 |
| 2011 | 2 | 62 | 64 |
| 2012 | 0 | 55 | 55 |
| 2013 | 1 | 70 | 71 |
| 2014 | 0 | 56 | 56 |
| 2015 | 2 | 53 | 55 |
| 2016 | 2 | 51 | 53 |
| 2017 | 0 | 41 | 41 |
| 2018 | 0 | 37 | 37 |
| 2019 | 0 | 55 | 55 |
| 2020 | 0 | 38 | 38 |
| 2021 | 0 | 36 | 36 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tumor Cells, Cultured" by people in Profiles.
-
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models. Neuro Oncol. 2024 Aug 05; 26(8):1509-1525.
-
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma. Neuro Oncol. 2024 May 03; 26(5):826-839.
-
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells. Nature. 2023 Aug; 620(7974):651-659.
-
Dimethylarginine Dimethylaminohydrolase - 1 expression is increased under tBHP-induced oxidative stress regulates nitric oxide production in PCa cells attenuates mitochondrial ROS-mediated apoptosis. Nitric Oxide. 2023 09 01; 138-139:70-84.
-
Highly Mimetic Ex Vivo Lung-Cancer Spheroid-Based Physiological Model for Clinical Precision Therapeutics. Adv Sci (Weinh). 2023 06; 10(16):e2206603.
-
Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells. Blood Cancer J. 2022 01 31; 12(1):23.
-
Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-?B Signaling in Non-Hodgkin's Lymphoma. Genes (Basel). 2022 01 11; 13(1).
-
RAR? activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway. Blood. 2022 01 06; 139(1):59-72.
-
Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004): in?vitro and in?vivo studies. J Enzyme Inhib Med Chem. 2021 Dec; 36(1):954-963.
-
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer. Exp Cell Res. 2021 12 15; 409(2):112930.